AVCN
Splash Beverage invests CDN$300,000 in cannabinoid biopharmaceutical firm Avicanna
Splash Beverage Group completed a strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company, as part of its transformation into a cannabinoid healthcare platform. The investment signals Splash's strategic pivot toward regulated medical cannabinoid products…